Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
2.
Am J Nurs ; 122(2): 45-48, 2022 Feb 01.
Article in English | MEDLINE | ID: covidwho-1684819

ABSTRACT

What nurses need to know as hospitals institute COVID-19 vaccine mandates.


Subject(s)
COVID-19/prevention & control , Vaccination/legislation & jurisprudence , COVID-19/epidemiology , COVID-19 Vaccines , Employment/legislation & jurisprudence , Hospitals , Humans , Pandemics , SARS-CoV-2
5.
New Solut ; 30(4): 311-323, 2021 02.
Article in English | MEDLINE | ID: covidwho-1024329

ABSTRACT

In 2020, medical cannabis is legal in thirty-six states and adult use ("recreational") cannabis is legal in fifteen, despite cannabis remaining illegal at the federal level. Up to 250,000 individuals work as full-time employees in cannabis. During the COVID-19 pandemic, California, Colorado, and other states deemed medical cannabis business as essential, raising occupational challenges and safety issues for cannabis employees. In 2020, interviews were conducted with Ethan, an extraction lab assistant in Las Vegas; Haylee, a trainer with a cannabis company in Sacramento; and Belinda, a Wisconsin-based occupational health and safety trainer, to showcase concerns and experiences in cannabis workplaces and training programs. Findings from interviews reveal pro-worker activities to promote workplace safety and labor unionism while large multistate operators seek to optimize profits and obstruct workers' rights. Knowledge gained through the interviews contributes to discussions to lessen the potential exposure of the cannabis workforce to COVID 19.


Subject(s)
COVID-19/epidemiology , Medical Marijuana/therapeutic use , Occupational Health/legislation & jurisprudence , Workplace/legislation & jurisprudence , Adult , Employment/legislation & jurisprudence , Humans , Organizational Policy , United States
8.
PLoS One ; 15(10): e0241167, 2020.
Article in English | MEDLINE | ID: covidwho-890192

ABSTRACT

Understanding the influence of COVID-19 on China's agricultural economy and the Chinese government's emergency measures to ease the economic impacts of viral spread can offer urgently-needed lessons while this virus continues to spread across the globe. Thus, this study collected over 750,000 words upon the topic of COVID-19 and agriculture from the largest two media channels in China: WeChat and Sina Weibo, and employed web crawler technology and text mining method to explore the influence of COVID-19 on agricultural economy and mitigation measures in China. The results show that: (1) the impact of COVID-19 on China's agricultural economy at the very first phase is mainly reflected in eight aspects as crop production, agricultural products supply, livestock production, farmers' income and employment, economic crop development, agricultural products sales model, leisure agriculture development, and agricultural products trade. (2) The government's immediate countermeasures include resuming agricultural production and farmers' work, providing financial support, stabilizing agricultural production and products supply, promoting agricultural products sale, providing subsidies, providing agricultural technology guidance and field management, and providing assistance to poor farmers to reduce poverty. (3) The order of government's immediate countermeasures is not all in line with the order of impact aspects, which indicates that more-tailored policies should be implemented to mitigate the strikes of COVID-19 on China's agricultural economy in the future.


Subject(s)
Betacoronavirus , Coronavirus Infections/economics , Coronavirus Infections/epidemiology , Crop Production/economics , Data Mining/methods , Farms/economics , Government Regulation , Pandemics/economics , Pneumonia, Viral/economics , Pneumonia, Viral/epidemiology , Animals , COVID-19 , China/epidemiology , Coronavirus Infections/virology , Crop Production/legislation & jurisprudence , Economic Development/legislation & jurisprudence , Employment/legislation & jurisprudence , Farmers/legislation & jurisprudence , Farms/legislation & jurisprudence , Financial Support , Humans , Livestock , Pneumonia, Viral/virology , SARS-CoV-2 , Social Media
9.
J Vasc Surg ; 72(6): 1856-1863, 2020 12.
Article in English | MEDLINE | ID: covidwho-863661

ABSTRACT

Although the coronavirus disease 2019 (COVID-19) pandemic has created havoc with the U.S healthcare system and physicians, the financial and contractual implications for physicians are now beginning to come to the forefront. Financial assistance from the federal government has mainly been received by hospitals, which have borne the brunt of the COVID-19 illness. Some physician groups have, or are, receiving assistance through a few programs, although the accelerated and advance payments have been suspended. Employed surgeons are now being furloughed, terminated, or persuaded to agree to a significant cut in pay, forego bonuses, or take leave without pay as healthcare systems and some physician groups have started to experience the consequences of halting elective procedures. Newly hired surgeons might be forced in a few cases to agree to delays in starting their employment, new amendments, changes in employment status, and other terms for fear of losing their employment. In the present report, we have explained some agreement terminology and options available to allow physicians to understand the terms of their employment agreement and make their decisions after consulting with an expert healthcare attorney.


Subject(s)
COVID-19/economics , Employment/economics , Financing, Government/economics , Income , Insurance, Health, Reimbursement/economics , Surgeons/economics , Ambulatory Care/economics , COVID-19/legislation & jurisprudence , Employment/legislation & jurisprudence , Financing, Government/legislation & jurisprudence , Humans , Insurance, Health, Reimbursement/legislation & jurisprudence , Policy Making , Practice Management, Medical/economics , Surgeons/legislation & jurisprudence , Telemedicine/economics , Time Factors , United States
11.
Med Leg J ; 88(2): 90-97, 2020 Jul.
Article in English | MEDLINE | ID: covidwho-505927

ABSTRACT

We consider various types of litigation that may follow the Covid-19 pandemic, including: claims against National Health Service (NHS) Trusts by patients who have contracted the coronavirus (or by their bereaved families), claims by NHS staff against their employer for a failure to provide any or adequate personal protective equipment or testing, commercial claims arising from the procurement of medical supplies, the potential liabilities to those who suffer adverse reactions to any vaccine and the guidance issued by the regulators in relation to subsequent disciplinary action.


Subject(s)
Betacoronavirus , Coronavirus Infections/epidemiology , Liability, Legal , Pneumonia, Viral/epidemiology , COVID-19 , Contracts/legislation & jurisprudence , Disease Transmission, Infectious/legislation & jurisprudence , Employee Discipline/legislation & jurisprudence , Employment/legislation & jurisprudence , Health Personnel , Humans , Malpractice/legislation & jurisprudence , Occupational Exposure/legislation & jurisprudence , Pandemics , SARS-CoV-2 , United Kingdom/epidemiology , Vaccination/legislation & jurisprudence
SELECTION OF CITATIONS
SEARCH DETAIL